Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

TherOx

TherOx?uq=w9if130k
1994 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Later Stage VC LATEST DEAL TYPE (In Progress)
$15M LATEST DEAL AMOUNT
15 INVESTORS
Description

Developer of a medical devices designed to elevate the standard of care for treatment of heart attack patients. The company's medical devices use supersaturated oxygen therapy that restores blood flow and cures damaged heart tissue by placing high concentration of oxygen inside the tissues, enabling patients to get themselves cured after a severe heart attack.

Website
Formerly Known As
TherO2x
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 17500 Cartwright Road
  • Suite 100
  • Irvine, CA 92614
  • United States

+1 (949) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore TherOx’s full profile, request a free trial.

TherOx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Later Stage VC 09-May-2018 $15M 00000 In Progress Generating Revenue
15. Later Stage VC (Series A) 01-Mar-2016 0000 00000 0000 Completed Generating Revenue
14. Later Stage VC 01-Jan-2014 00.000 00000 Completed Generating Revenue
13. Share Repurchase 18-Nov-2010 00000 Completed Clinical Trials - Phase 2
12. IPO 03-Feb-2009 00000 Cancelled Clinical Trials - Phase 2
11. Later Stage VC (Series J) 20-Feb-2008 0000 00000 00000 Completed Clinical Trials - Phase 2
10. Later Stage VC (Series I) 21-Jul-2005 000.00 000.00 000.00 Completed Clinical Trials - Phase 1
9. Secondary Transaction - Private 01-May-2004 000.00 Completed Generating Revenue
8. Later Stage VC (Series H) 01-Sep-2000 $30.3M $52.1M 000.00 Completed Generating Revenue
7. Later Stage VC (Series G) 01-Dec-1997 $12.2M $21.8M 000.00 Completed Pre-Clinical Trials
To view this company’s complete deal history including valuation and funding, request access »

TherOx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 000,000,000 00.000000 00 00.00 00.00 00 00.00 000
To view this company’s complete Cap Table, request access »

TherOx Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Blue Orion Management Solutions Corporation Minority 000 0000 000000 0
DAG Ventures Venture Capital Minority 000 0000 000000 0
Sears Capital Management Venture Capital Minority 000 0000 000000 0
ZOLL Medical Corporation Minority 000 0000 000000 0
Cross Creek Advisors Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

TherOx Executive Team (7)

Name Title Board
Seat
Contact
Info
Kevin Larkin President, Board Member & Chief Executive Officer
Denise Strogatz Director, Finance
John Gilkerson Director, Manufacturing & Operatons
Jeff Kay Director, Quality Systems
Jeffrey Creech Ph.D Vice President, Research, Regulatory, and Clinical Programs

2 Former Executives

You’re viewing 5 of 7 executives. Get the full list »

TherOx Board Members (9)

Name Representing Role Since Contact
Info
C. Larkin TherOx Board Member 000 0000
Frank Fischer Self Chairman 000 0000
James Palazzolo ZOLL Medical Board Member 000 0000
Joseph Lacob Kleiner Perkins Board Member 000 0000
Keith Grossman Self Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 9 board members. Get the full list »